Orthofix Medical Stock Price, News & Analysis (NASDAQ:OFIX)

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Orthofix Medical Inc (NASDAQ:OFIX) issued its quarterly earnings data on Monday, August, 5th. The medical device company reported $0.28 earnings per share for the quarter, missing the consensus estimate of $0.40 by $0.12. The medical device company earned $115.85 million during the quarter, compared to analysts' expectations of $115.17 million. Orthofix Medical had a return on equity of 9.50% and a net margin of 1.75%. The company's revenue was up 3.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.42 earnings per share. View Orthofix Medical's Earnings History.

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, October 28th 2019. View Earnings Estimates for Orthofix Medical.

Orthofix Medical will be holding an earnings conference call on Monday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Orthofix Medical updated its FY19 earnings guidance on Monday, August, 5th. The company provided earnings per share guidance of $1.75-1.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.78. The company issued revenue guidance of $472-477 million, compared to the consensus revenue estimate of $473.70 million.

2 brokerages have issued 12-month price objectives for Orthofix Medical's stock. Their forecasts range from $60.00 to $60.00. On average, they expect Orthofix Medical's share price to reach $60.00 in the next year. This suggests a possible upside of 13.0% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical.

News headlines about OFIX stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthofix Medical earned a news sentiment score of 0.9 on InfoTrie's scale. They also assigned news coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Orthofix Medical.

Orthofix Medical saw a decline in short interest in the month of September. As of September 30th, there was short interest totalling 409,400 shares, a decline of 12.9% from the August 30th total of 470,100 shares. Based on an average trading volume of 121,100 shares, the days-to-cover ratio is presently 3.4 days. Currently, 2.2% of the shares of the stock are sold short. View Orthofix Medical's Current Options Chain.

Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Hologic (HOLX), Steris (STE) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL), Zogenix (ZGNX), Allergan (AGN), Edwards Lifesciences (EW), Zoetis (ZTS) and Biogen (BIIB).

Orthofix Medical's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Dalton Greiner Hartman Maher & Co. (1.76%), Alberta Investment Management Corp (0.46%), Assenagon Asset Management S.A. (0.41%), Rhumbline Advisers (0.32%) and State of Alaska Department of Revenue (0.08%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

OFIX stock was bought by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Dalton Greiner Hartman Maher & Co., Alberta Investment Management Corp, State of Alaska Department of Revenue and Rhumbline Advisers. View Insider Buying and Selling for Orthofix Medical.

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OFIX stock can currently be purchased for approximately $53.12.

Orthofix Medical has a market capitalization of $1.01 billion and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

The official website for Orthofix Medical is http://www.orthofix.com/.

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]